PharmGen Science, Inc. Logo

PharmGen Science, Inc.

004720 | KO

Overview

Corporate Details

ISIN(s):
KR7004720009
LEI:
Country:
South Korea
Address:
경기 화성시 향남면 상신리 향남제약공단 902-5, 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-19 00:00
Interim / Quarterly Report
[기재정정]반기보고서 (2025.06)
Korean 1.4 MB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-08-12 00:00
Share Issue/Capital Change
전환청구권ㆍ신주인수권ㆍ교환청구권행사
Korean 15.9 KB
2025-06-12 00:00
Share Issue/Capital Change
전환청구권ㆍ신주인수권ㆍ교환청구권행사
Korean 14.0 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.8 MB
2025-04-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-04-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-04-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-04-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.0 KB
2025-04-14 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 110.0 KB
2025-04-11 00:00
Share Issue/Capital Change
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Korean 14.4 KB
2025-04-10 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 677.5 KB
2025-04-03 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-03 00:00
Major Shareholding Notification
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 34.9 KB
2025-03-31 00:00
AGM Information
정기주주총회결과
Korean 28.6 KB

Automate Your Workflow. Get a real-time feed of all PharmGen Science, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PharmGen Science, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PharmGen Science, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Immix Biopharma, Inc. Logo
Developing safer cell therapies for AL Amyloidosis and hematologic malignancies.
United States of America
IMMX
IMMUCELL CORP /DE/ Logo
Develops biotech health products for disease prevention in dairy and beef cattle.
United States of America
ICCC
ImmuneOncia Therapeutics, Inc. Logo
A biopharma firm developing immune checkpoint inhibitors for cancer immunotherapy.
South Korea
424870
ImmunityBio, Inc. Logo
Develops immunotherapies activating the immune system to fight cancer and infectious diseases.
United States of America
IBRX
Immuno-Biological Laboratories Co., Ltd. Logo
Develops and supplies immunological reagents and diagnostics for research and drug discovery.
Japan
4570
Immunocore Holdings plc Logo
Pioneering TCR bispecific immunotherapies for cancer, infectious, and autoimmune diseases.
United States of America
IMCR
Immunome Inc. Logo
Develops targeted oncology therapies, like ADCs, for cancers with high unmet needs.
United States of America
IMNM
Immuron Ltd Logo
Develops oral antibodies from bovine colostrum for digestive and immune health.
United States of America
IMRN
Imunon, Inc. Logo
Developing DNA-based immunotherapies for oncology and infectious diseases.
United States of America
IMNN
IN8BIO, INC. Logo
Clinical-stage biopharma developing gamma-delta T cell therapies for solid & hematological tumors.
United States of America
INAB

Talk to a Data Expert

Have a question? We'll get back to you promptly.